Indefinite Delivery Contract 75F40126D00011
- Not listed
- The Food and Drug Administration awarded an indefinite-delivery contract to Denver Health and Hospital Authority for non-medical use surveillance data reporting and analysis services, with a contract ceiling of $8.5 million and an award date of September 30, 2026. This is a multiple-award IDIQ; the FDA anticipated awarding a maximum of two contracts under the same solicitation. Place of performance is Silver Spring, Maryland. The contract supports post-marketing surveillance data collection...
- This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances. Two task orders have been issued under this IDC. The...
- The Food and Drug Administration awarded an indefinite-delivery contract to Vets Synergetic Group LLC, an SBA 8(a) Joint Venture and minority-owned small disadvantaged business, on June 4, 2024, with a ceiling value of $99.883 million and a completion date of June 9, 2028. This is a single-award, Competitive 8(a) set-aside vehicle designated the FDA Scientific Support IDIQ. Place of performance spans multiple FDA facilities including Silver Spring, Maryland; Leesburg, Virginia; Berwyn Heights,...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...
- The Food and Drug Administration awarded a single-award indefinite-delivery contract to Source Healthcare Analytics LLC with a ceiling of $45 million on May 22, 2020, to provide access to outpatient prescription and patient-level drug utilization data supporting the agency's drug safety monitoring efforts. The contract has no set-aside designation and is structured as a firm fixed-price vehicle with a completion date of May 21, 2025. Work is performed in Penllyn, Pennsylvania. The IDIQ...
- This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit organization specializing in healthcare data, analytics, and clinical research services. The contract has a ceiling value of $16,803,000.00 and a period of performance from August 20, 2025, to August 21, 2027. The purpose of this IDC is to provide the FDA's Center for Drug Evaluation and Research with comprehensive access to outpatient...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Research Triangle Institute (RTI International), a non-profit research organization, for the "Economic Studies of FDA Regulations" program. The $9,901,000 multiple-award IDC has a period of performance through September 14, 2024. Under this IDC, RTI has been issued several delivery orders, including: A $0 task order to develop an economic...
- The Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Contract to Syneos Health Research & Insights LLC on May 16, 2023, with a contract ceiling value of $3.4 million and a performance period extending through May 16, 2027. The contract was awarded without a set-aside restriction and originated from a competitive solicitation posted on March 13, 2023, with proposals due on April 17, 2023. Under this indefinite delivery vehicle, Syneos Health Research &...
- The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to the National Academy of Sciences with a potential value of $30,000,000.00. The contract establishes a forum for the agency to convene committees for assessment, evaluations, and studies related to public health issues. Five task orders have been awarded against the contract to date, with periods of performance ranging from September 2022 through September 2025. Task orders...
The Food and Drug Administration awarded an Indefinite Delivery Contract to Integrated Behavioral Health, Inc. with a ceiling of $8,500,000 on September 30, 2026. This is a multiple-award vehicle, with the FDA anticipating a maximum of two IDIQs under this solicitation. The contract supports Non-Medical Use (NMU) Surveillance services, delivering post-marketing surveillance data reporting and analysis on prescription and over-the-counter drug nonmedical use, illicit substance use, and emerging regulatory substances. Work is performed at Silver Spring, Maryland. The originating solicitation required contractors to maintain access to a minimum of 50,000 individual subjects entering or being assessed for substance use disorder treatment with geographic diversity across all four U.S. census regions and a minimum of ten years of historical data from 2016 to present. Deliverables include summary reports, ad hoc analyses, and focused topic-specific studies provided through treatment center data. Compensation is structured as fully burdened hourly labor rates across seven specified categories: Project Manager, Senior Computer Systems Analyst, Statistician, Pharmacist, Epidemiologist, Survey Scientist, and Subject Matter Expert. The period of performance runs from September 30, 2026 through September 29, 2031, with a minimum guaranteed amount of $3,000 obligated at award. Individual task orders may extend up to 36 months beyond the IDIQ expiration. The FDA anticipates issuing 2–4 task orders over the life of the contract with 0–2 ad hoc analytic requests issued annually.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 5/17/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Non-medical Use (NMU) Data Report Services | 75F40126R00013 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 2/18/26, 1:28 PM |